by CCHR National Affairs Office | Dec 17, 2025
Connecticut stands as an example of the growing problem of electroconvulsive therapy (ECT) performed on patients without their consent, allowed under many states’ laws despite the procedure’s known risks of serious side effects and no proof of effectiveness. Data...
by CCHR National Affairs Office | Nov 26, 2025
Potential risks for expectant mothers and their babies from SSRI antidepressants should be more fully disclosed in prescribing information and in discussions between physicians and their pregnant patients, experts say, allowing for more informed decisions about...
by CCHR National Affairs Office | Nov 19, 2025
The Canadian Task Force on Preventive Health Care agrees with other investigative bodies which have concluded that using a questionnaire to screen adults for depression has no clear benefit for patients’ health. A new guideline issued by the Canadian Task Force on...
by CCHR National Affairs Office | Oct 31, 2025
Survey responses showing little or no benefit for most electroshock recipients, along with long-term memory loss for many, led researchers to call for a suspension of the procedure until large-scale, high-quality research can determine whether benefits outweigh the...
by CCHR National Affairs Office | Oct 21, 2025
Prescribing drugs for preschoolers soon after diagnosis of ADHD conflicts with American Academy of Pediatrics guideline for nondrug approaches first. Research has indicated the ADHD label itself and the stimulant drugs that may be prescribed as treatment can be...
